Myosana Therapeutics

Private

Seattle, WashingtonHealthcare & Life Scienceshttps://www.myosanatherapeutics.com/

Last Round

Crowdfunding

Nov 13, 2025

Est. Valuation

$27.38M

Total Funding Raised

$6.35M

Company Overview

Myosana Therapeutics is a biotechnology company that develops a muscle-specific non-viral gene therapy platform for the treatment of neuromuscular and cardiac diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapygene deliverynon-viral deliveryDMDDuchenne muscular dystrophyneuromuscular diseasegenetic medicinebiotechX-linked myotubular myopathyMTMdrug delivery platformrare disease therapyadeno-associated virusAAVgenetic engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myosana Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Myosana Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Myosana Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Crowdfunding	Nov 13, 2025
Seed	Jan 25, 2023
Grant	Aug 26, 2021
Seed	Apr 22, 2020

View all Funding Rounds

Myosana Therapeutics Investors

Notable investors and investment history

Myosana Therapeutics investors
Investor	Rounds
CureDuchenne Ventures	Seed, Crowdfunding
Parent Project Muscular Dystrophy	Grant, Seed, Crowdfunding
Muscular Dystrophy Association	Seed, Crowdfunding

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 26, 2021
$350K grant from Parent Project Muscular Dystrophy

View all signals

Myosana Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Myosana Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Myosana Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington

Employee Range3

Year Founded2018

Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.